Frontera Therapeutics
Shama Pilankar is a Senior Associate Scientist at Frontera Therapeutics since September 2021, specializing in the development and standardization of ELISA assays and plasmid transfection. Previously, Shama served as an Analytical Development Specialist at uniQure, providing technical support and culturing cells for analytical assays. Shama's career began as a Junior Research Associate at Ipca Laboratories Limited and further included roles as an Analytical Development Coop and Research Volunteer, demonstrating a strong background in laboratory techniques and project support. Educational qualifications include a Master of Science in Biotechnology from Northeastern University and a Bachelor's degree in Biotechnology from MGM College of Engineering & Technology.
Frontera Therapeutics
Frontera Therapeutics is an AAV gene therapy company with the mission to establish a low-cost and scalable platform, to develop and produce high-quality and affordably priced rAAV therapies for the global market.